Latest News
Search News
AR alterations in prostate cancer
16th May 2019
Recent findings from a study published in JAMA Oncology have identified genetic markers within blood samples which may indicate whether patients with prostate cancer will respond to hormonal therapies. The study may represent an important step forward for the development of more personalised treatments for advanced prostate cancer.
Read more
Sun Awareness Week
9th May 2019
As the summer months approach and the weather gets warmer, it is important to be aware of the risks associated with prolonged exposure to the sun. This week (6th-12thMay) is […]
Read more
IBD and bowel cancer
29th April 2019
April is Bowel Cancer Awareness Month. We recently spoke with Dr Kit Curtius about her work which focuses on understanding how normal tissues evolve to become cancerous, with a particular interest in gastrointestinal pre-malignancies such as inflammatory bowel disease.
Read more
Eliminating cancer stem cells
25th April 2019
Research published today in Cell Stem Cell has discovered a protein which drives an aggressive form of blood cancer, acute myeloid leukaemia (AML). Inactivation of this protein selectively compromises leukaemic cells while promoting normal blood cell functions.
Read more
HPV and cervical screening
12th April 2019
The American Society for Colposcopy and Cervical Pathology (ASCCP) has awarded their prize for the Best Overall Scientific Abstract 2019 to Professor Jack Cuzick, Director, Wolfson Institute of Preventive Medicine and Head, Centre for Cancer Prevention, and his co-authors.
Read more
Therapy for high-grade glioma
2nd April 2019
A phase I clinical trial that set out to assess the safety of a new combination therapy for a type of aggressive brain tumour has found the treatment to be well tolerated in patients. The trial used a treatment combination of ADI-PEG20, pemetrexed and cisplatin, which showed encouraging efficacy in patients with recurrent high-grade gliomas (HGGs), a disease for which little progress has been made over the last few decades.
Read more